Dr Manuel Roberto De Aguirre, MD | |
789 Central Ave, Dover, NH 03820-2526 | |
(603) 740-9713 | |
(603) 740-2447 |
Full Name | Dr Manuel Roberto De Aguirre |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 20 Years |
Location | 789 Central Ave, Dover, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477882967 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 17052 (New Hampshire) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bridgeport Hospital | Bridgeport, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
Inspire Pharmaceuticals, Inc. announced today financial results for the second quarter ended June 30, 2010, reporting a net loss of $8.8 million or ($0.11) per share, an improvement from the second quarter of 2009 during which the Company incurred a net loss of $9.5 million or ($0.17) per share.
A study has found that children inserted with PICCs are at higher risk of developing blood clots called venous thromboembolism.
The current recommended minimum daily dose of vitamin D is not sufficient to restore healthy vitamin D levels in overweight or obese blacks, researchers report.
Speaking today in Barcelona at the Fifth Peptide Engineering Meeting, Compugen Ltd. project manager Dr. Yossef Kliger provided an overview of Compugen's DAC Blockers Platform and reviewed disease model data for selected product candidates.
› Verified 4 days ago
Entity Name | Northeast Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Inspire Pharmaceuticals, Inc. announced today financial results for the second quarter ended June 30, 2010, reporting a net loss of $8.8 million or ($0.11) per share, an improvement from the second quarter of 2009 during which the Company incurred a net loss of $9.5 million or ($0.17) per share.
A study has found that children inserted with PICCs are at higher risk of developing blood clots called venous thromboembolism.
The current recommended minimum daily dose of vitamin D is not sufficient to restore healthy vitamin D levels in overweight or obese blacks, researchers report.
Speaking today in Barcelona at the Fifth Peptide Engineering Meeting, Compugen Ltd. project manager Dr. Yossef Kliger provided an overview of Compugen's DAC Blockers Platform and reviewed disease model data for selected product candidates.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Manuel Roberto De Aguirre, MD 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 740-9713 | Dr Manuel Roberto De Aguirre, MD 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 740-9713 |
News Archive
Inspire Pharmaceuticals, Inc. announced today financial results for the second quarter ended June 30, 2010, reporting a net loss of $8.8 million or ($0.11) per share, an improvement from the second quarter of 2009 during which the Company incurred a net loss of $9.5 million or ($0.17) per share.
A study has found that children inserted with PICCs are at higher risk of developing blood clots called venous thromboembolism.
The current recommended minimum daily dose of vitamin D is not sufficient to restore healthy vitamin D levels in overweight or obese blacks, researchers report.
Speaking today in Barcelona at the Fifth Peptide Engineering Meeting, Compugen Ltd. project manager Dr. Yossef Kliger provided an overview of Compugen's DAC Blockers Platform and reviewed disease model data for selected product candidates.
› Verified 4 days ago
Dr. Mark Lee Dick, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Fl 5, Dover, NH 03820 Phone: 603-609-6800 | |
Mrs. Jhansi Lakshmi Maradana, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Ravi Teja Pasam, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2503 Fax: 603-740-2497 | |
Paul C Tung, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 10 Members Way, Suite 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Amy Claire Bessnow, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2694 | |
Dylan Thomas, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Alison M Sollee, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Fl 5, Dover, NH 03820 Phone: 603-609-6800 |